Hallmarks of triple negative breast cancer emerging at last?

被引：38

作者：

Bernardi, Rosa ^{[1
]}

Gianni, Luca ^{[2
]}

机构：

[1] Ist Sci San Raffaele, Div Mol Oncol, I-20132 Milan, Italy

[2] Hosp San Raffaele, Dept Med Oncol, I-20132 Milan, Italy

来源：

CELL RESEARCH | 2014年 / 24卷 / 08期

关键词：

D O I：

10.1038/cr.2014.61

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

Triple negative breast cancers (TNBC) are clinically heterogeneous but mostly aggressive malignancies devoid of expression of the estrogen, progesterone and HER2 (ERBB2 or NEU) receptors. Recent evidence shows that basal endoplasmic reticulum stress (ERS) is typically activated in TNBC and cooperates with hypoxia signaling to promote tumor progression and relapse; ERS and hypoxia response may therefore be among the long-searched hallmarks of TNBC.

引用

页码：904 / 905

页数：2

共 50 条

[31] EphA2: An emerging target in triple-negative breast cancer
Eckhardt, Bedrich L.
Torres, Angie M.
Woodward, Wendy A.
Krishnamurthy, Savitri
Meric-Bernstam, Funda
Ueno, Naoto T.
CANCER RESEARCH, 2018, 78 (04)
[32] Molecular Biology Mechanisms and Emerging Therapeutics of Triple-Negative Breast Cancer
Zhang, Zhiying
Zhang, Rui
Li, Donghai
BIOLOGICS-TARGETS & THERAPY, 2023, 17 : 113 - 128
[33] Is androgen receptor targeting an emerging treatment strategy for triple negative breast cancer?
Anestis, Aristomenis
Karamouzis, Michalis V.
Dalagiorgou, Georgia
Papavassiliou, Athanasios G.
CANCER TREATMENT REVIEWS, 2015, 41 (06) : 547 - 553
[34] Triple negative breast cancer: special histological types and emerging therapeutic methods
Lu Cao
Yun Niu
Cancer Biology & Medicine, 2020, (02) : 293 - 306
[35] Triple negative breast cancer: special histological types and emerging therapeutic methods
Lu Cao
Yun Niu
Cancer Biology & Medicine, 2020, 17 (02) : 293 - 306
[36] Early Triple Negative Breast Cancer: Conventional Treatment and Emerging Therapeutic Landscapes
Diana, Anna
Carlino, Francesca
Franzese, Elisena
Oikonomidou, Olga
Criscitiello, Carmen
De Vita, Ferdinando
Ciardiello, Fortunato
Orditura, Michele
CANCERS, 2020, 12 (04)
[37] Triple negative breast cancer: Emerging therapeutic modalities and novel combination therapies
Lee, Alice
Djamgoz, Mustafa B. A.
CANCER TREATMENT REVIEWS, 2018, 62 : 110 - 122
[38] Breast cancer stem cells in triple negative vs. non triple negative breast cancer
Comanescu, M. V.
Dobre, M.
Ardeleanu, C.
Butur, G.
Bussolati, G.
HISTOPATHOLOGY, 2012, 61 : 17 - 17
[39] Emerging Predictive Biomarkers of Response to Platinum Therapy in Triple-Negative Breast Cancer
Mego M.
Reuben J.M.
Current Breast Cancer Reports, 2015, 7 (4) : 224 - 231
[40] Molecular Mechanisms and Emerging Therapeutic Targets of Triple-Negative Breast Cancer Metastasis
Neophytou, Christiana
Boutsikos, Panagiotis
Papageorgis, Panagiotis
FRONTIERS IN ONCOLOGY, 2018, 8

← 1 2 3 4 5 →